Skip to main content
Clinical Trials/NCT06792318
NCT06792318RecruitingNot Applicable

Use of Fibroblast Activation Protein Inhibitor (FAPI) PET-CT Before Surgery in Patient with Endometriosis

Ziv Hospital1 site in 1 country30 target enrollmentStarted: March 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Diagnostic Accuracy of FAPI PET-CT in Endometriosis Detection

Study Overview

Brief Summary

Patients with suspected endometriosis scheduled for surgery will be identified. They will be asked to participate in a study evaluating the feasibility of FAPI PET-CT in diagnosing endometriosis. The results will be compared with surgical findings, pathology, and other imaging techniques if available (i.e., MRI, US).

Detailed Description

This study investigates FAPI PET-CT imaging in endometriosis diagnosis using a standardized protocol. Participants will undergo two imaging sessions after a single FAPI injection:

First Session:

Initial scan at 10 minutes post-injection Follow-up scan at 30 minutes

Second Session:

Additional scans at 60 and 80 minutes post-injection

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Masking Description

Open label study. The surgeon operates based on PET-CT findings, and the pathologist examines specimens from lesions detected on PET-CT

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female participants aged 18-45 years
  • •Clinical suspicion of endometriosis based on symptoms
  • •Scheduled for diagnostic/therapeutic laparoscopic surgery
  • •Ability to understand and provide written informed consent
  • •Completed and signed Radiation Exposure Documentation Form

Exclusion Criteria

  • •Pregnant women or women who are breastfeeding
  • •History of pelvic radiation therapy
  • •Known active malignancy
  • •Exposure to ionizing radiation for medical purposes within 12 months prior to enrollment

Arms & Interventions

FAPI PET-CT Diagnostic Arm

Experimental

Participants undergo FAPI PET-CT imaging at multiple timepoints (10, 30, 60, and 80 minutes post-injection) using a single FAPI dose. Each participant will then undergo laparoscopic surgery with tissue sampling for pathological confirmation of endometriotic lesions.

Intervention: FAPI PET-CT (Diagnostic Test)

Outcomes

Primary Outcomes

Diagnostic Accuracy of FAPI PET-CT in Endometriosis Detection

Time Frame: Within 1 month post-surgery

Assessment of FAPI PET-CT diagnostic performance through calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Surgical findings with histological confirmation will serve as the reference standard for evaluation.

Secondary Outcomes

  • Comparison of FAPI PET-CT with Conventional Imaging(Within 1 month post-surgery)

Investigators

Sponsor
Ziv Hospital
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Israel Sandler

MD

Ziv Medical Center

Study Sites (1)

Loading locations...

Similar Trials